Department of Analytical Chemistry, Shanghai Institute of Materia and Medica, Chinese Academy of Sciences, Shanghai 201203, China.
University of the Chinese Academy of Sciences, 19A Yuquan Road, Beijing 100049, China.
Molecules. 2021 Jan 22;26(3):576. doi: 10.3390/molecules26030576.
During the past decades, solution nuclear magnetic resonance (NMR) spectroscopy has demonstrated itself as a promising tool in drug discovery. Especially, fragment-based drug discovery (FBDD) has benefited a lot from the NMR development. Multiple candidate compounds and FDA-approved drugs derived from FBDD have been developed with the assistance of NMR techniques. NMR has broad applications in different stages of the FBDD process, which includes fragment library construction, hit generation and validation, hit-to-lead optimization and working mechanism elucidation, etc. In this manuscript, we reviewed the current progresses of NMR applications in fragment-based drug discovery, which were illustrated by multiple reported cases. Moreover, the NMR applications in protein-protein interaction (PPI) modulators development and the progress of in-cell NMR for drug discovery were also briefly summarized.
在过去的几十年中,溶液核磁共振(NMR)光谱已证明是药物发现中一种很有前途的工具。特别是,基于片段的药物发现(FBDD)从 NMR 的发展中受益匪浅。借助 NMR 技术,已经开发出了多种候选化合物和 FDA 批准的药物,这些药物都源自 FBDD。NMR 在 FBDD 过程的不同阶段都有广泛的应用,包括片段文库构建、命中生成和验证、命中到先导优化以及作用机制阐明等。在本文中,我们通过多个报道案例,综述了 NMR 在基于片段的药物发现中的应用进展。此外,还简要总结了 NMR 在蛋白质-蛋白质相互作用(PPI)调节剂开发中的应用以及用于药物发现的细胞内 NMR 的进展。